Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 6;68(3):e0124723.
doi: 10.1128/aac.01247-23. Epub 2024 Jan 30.

Characterization of the resistome and predominant genetic lineages of Gram-positive bacteria causing keratitis

Affiliations

Characterization of the resistome and predominant genetic lineages of Gram-positive bacteria causing keratitis

Camille André et al. Antimicrob Agents Chemother. .

Abstract

Bacterial keratitis is a vision-threatening infection mainly caused by Gram-positive bacteria (GPB). Antimicrobial therapy is commonly empirical using broad-spectrum agents with efficacy increasingly compromised by the emergence of antimicrobial resistance. We used a combination of phenotypic tests and genome sequencing to identify the predominant lineages of GPB causing keratitis and to characterize their antimicrobial resistance patterns. A total of 161 isolates, including Staphylococcus aureus (n = 86), coagulase-negative staphylococci (CoNS; n = 34), Streptococcus spp. (n = 34), and Enterococcus faecalis (n = 7), were included. The population of S. aureus isolates consisted mainly of clonal complex 5 (CC5) (30.2%). Similarly, the population of Staphylococcus epidermidis was homogenous with most of them belonging to CC2 (78.3%). Conversely, the genetic population of Streptococcus pneumoniae was highly diverse. Resistance to first-line antibiotics was common among staphylococci, especially among CC5 S. aureus. Methicillin-resistant S. aureus was commonly resistant to fluoroquinolones and azithromycin (78.6%) and tobramycin (57%). One-third of the CoNS were resistant to fluoroquinolones and 53% to azithromycin. Macrolide resistance was commonly caused by erm genes in S. aureus, mphC and msrA in CoNS, and mefA and msr(D) in streptococci. Aminoglycoside resistance in staphylococci was mainly associated with genes commonly found in mobile genetic elements and that encode for nucleotidyltransferases like ant(4')-Ib and ant(9)-Ia. Fluroquinolone-resistant staphylococci carried from 1 to 4 quinolone resistance-determining region mutations, mainly in the gyrA and parC genes. We found that GPB causing keratitis are associated with strains commonly resistant to first-line topical therapies, especially staphylococcal isolates that are frequently multidrug-resistant and associated with major hospital-adapted epidemic lineages.

Keywords: Gram-positive bacteria; MRSA; antimicrobial resistance; genomics; keratitis; resistome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
SNP-based maximum-likelihood phylogenetic tree of the S. aureus keratitis population generated from a core-genome alignment. All comparator genomes included in the tree were in italic.
Fig 2
Fig 2
SNP-based maximum-likelihood phylogenetic tree of the S. epidermidis keratitis population generated from a core-genome alignment. All comparator genomes included in the tree were in italic.
Fig 3
Fig 3
SNP-based maximum-likelihood phylogenetic tree of the S. pneumoniae keratitis population generated from a core-genome alignment. All comparator genomes included in the tree were in italic.

Similar articles

Cited by

References

    1. Bourne RRA, Jonas JB, Bron AM, Cicinelli MV, Das A, Flaxman SR, Friedman DS, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Peto T, Saadine J, Silvester AJ, Tahhan N, Taylor HR, Varma R, Wong TY, Resnikoff S, Vision Loss Expert Group of the Global Burden of Disease Study . 2018. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol 102:575–585. doi:10.1136/bjophthalmol-2017-311258 - DOI - PMC - PubMed
    1. Collier SA, Gronostaj MP, MacGurn AK, Cope JR, Awsumb KL, Yoder JS, Beach MJ, Centers for Disease Control and Prevention (CDC) . 2014. Estimated burden of keratitis — United States, 2010. MMWR Morb Mortal Wkly Rep 63:1027–1030. - PMC - PubMed
    1. Ung L, Bispo PJM, Shanbhag SS, Gilmore MS, Chodosh J. 2019. The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol 64:255–271. doi:10.1016/j.survophthal.2018.12.003 - DOI - PMC - PubMed
    1. Zhang Z, Cao K, Liu J, Wei Z, Xu X, Liang Q. 2022. Pathogens and antibiotic susceptibilities of global bacterial keratitis: a meta-analysis. Antibiotics (Basel) 11:238. doi:10.3390/antibiotics11020238 - DOI - PMC - PubMed
    1. Lin A, Rhee MK, Akpek EK, Amescua G, Farid M, Garcia-Ferrer FJ, Varu DM, Musch DC, Dunn SP, Mah FS, American Academy of Ophthalmology Preferred Practice Pattern Cornea and External Disease Panel . 2019. Bacterial keratitis preferred practice pattern. Ophthalmology 126:P1–P55. doi:10.1016/j.ophtha.2018.10.018 - DOI - PubMed

Publication types